IL145885A0 - Membrane disruptive peptides covalently oligomerized - Google Patents
Membrane disruptive peptides covalently oligomerizedInfo
- Publication number
- IL145885A0 IL145885A0 IL14588500A IL14588500A IL145885A0 IL 145885 A0 IL145885 A0 IL 145885A0 IL 14588500 A IL14588500 A IL 14588500A IL 14588500 A IL14588500 A IL 14588500A IL 145885 A0 IL145885 A0 IL 145885A0
- Authority
- IL
- Israel
- Prior art keywords
- oligomerized
- membrane disruptive
- peptides covalently
- disruptive peptides
- covalently
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
- C07K14/43572—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from bees
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Insects & Arthropods (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9909567.1A GB9909567D0 (en) | 1999-04-26 | 1999-04-26 | A modified membrane disruptive peptide |
US13237699P | 1999-05-04 | 1999-05-04 | |
GBGB9916912.0A GB9916912D0 (en) | 1999-07-19 | 1999-07-19 | A modified membrane disruptive peptide |
GBGB9928303.8A GB9928303D0 (en) | 1999-11-30 | 1999-11-30 | A modified membrane disruptive peptide |
PCT/GB2000/001588 WO2000064929A1 (en) | 1999-04-26 | 2000-04-25 | Membrane disruptive peptides covalently oligomerized |
Publications (1)
Publication Number | Publication Date |
---|---|
IL145885A0 true IL145885A0 (en) | 2002-07-25 |
Family
ID=27451899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14588500A IL145885A0 (en) | 1999-04-26 | 2000-04-25 | Membrane disruptive peptides covalently oligomerized |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1173474A1 (de) |
JP (1) | JP2002544126A (de) |
KR (1) | KR20020007382A (de) |
CN (1) | CN1349543A (de) |
AU (1) | AU4584800A (de) |
CA (1) | CA2370284A1 (de) |
HK (1) | HK1044003A1 (de) |
IL (1) | IL145885A0 (de) |
WO (1) | WO2000064929A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7446099B2 (en) | 2004-02-27 | 2008-11-04 | Nitto Denko Corporation | Compositions and methods for biodegradable polymer-peptide mediated transfection |
CN106589102A (zh) * | 2016-11-30 | 2017-04-26 | 青岛大学 | Orexin‑A聚乙二醇化修饰物制备及用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL1010692C2 (nl) * | 1998-12-01 | 2000-06-06 | Stichting Tech Wetenschapp | Antivirale peptiden. |
-
2000
- 2000-04-25 EP EP00927442A patent/EP1173474A1/de not_active Withdrawn
- 2000-04-25 AU AU45848/00A patent/AU4584800A/en not_active Abandoned
- 2000-04-25 JP JP2000614278A patent/JP2002544126A/ja not_active Withdrawn
- 2000-04-25 WO PCT/GB2000/001588 patent/WO2000064929A1/en not_active Application Discontinuation
- 2000-04-25 CA CA002370284A patent/CA2370284A1/en not_active Abandoned
- 2000-04-25 KR KR1020017013492A patent/KR20020007382A/ko not_active Application Discontinuation
- 2000-04-25 CN CN00806815A patent/CN1349543A/zh active Pending
- 2000-04-25 IL IL14588500A patent/IL145885A0/xx unknown
-
2002
- 2002-05-14 HK HK02103648.8A patent/HK1044003A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2000064929A1 (en) | 2000-11-02 |
AU4584800A (en) | 2000-11-10 |
CN1349543A (zh) | 2002-05-15 |
CA2370284A1 (en) | 2000-11-02 |
HK1044003A1 (zh) | 2002-10-04 |
JP2002544126A (ja) | 2002-12-24 |
EP1173474A1 (de) | 2002-01-23 |
KR20020007382A (ko) | 2002-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6906800A (en) | Membrane associated proteins | |
AU7358700A (en) | Dolastatin peptides | |
IL146832A0 (en) | Peptides | |
EP1173467A4 (de) | Von chemokinen abgeleitete synthetische peptide | |
AU6223700A (en) | Gtp-binding associated proteins | |
GB9918156D0 (en) | Synthetic peptides | |
EP1185558A4 (de) | Peptide mit preptid-funktionalität | |
GB9918155D0 (en) | Proteins and peptides | |
EP1147130A4 (de) | Alpha-conotoxin-peptide | |
EP1159288A4 (de) | Alpha-conotoxin-peptide | |
IL145885A0 (en) | Membrane disruptive peptides covalently oligomerized | |
GB9904695D0 (en) | Peptide | |
GB0120713D0 (en) | Peptides | |
AU3506800A (en) | Leukocyte- and blood-associated proteins | |
AU3774000A (en) | Conformationally constrained peptides | |
GB9908920D0 (en) | Peptide | |
EP1151100A4 (de) | Tau-conotoxin peptide | |
HK1045173A1 (zh) | 多肽 | |
AU1228201A (en) | Umlr polypeptides | |
GB0202889D0 (en) | Peptides (assay) | |
GB9909567D0 (en) | A modified membrane disruptive peptide | |
GB9916912D0 (en) | A modified membrane disruptive peptide | |
GB9928303D0 (en) | A modified membrane disruptive peptide | |
GB9907911D0 (en) | Peptides | |
GB9928325D0 (en) | Peptides |